RETRACTED: SIRT1 Protects against α-Synuclein Aggregation by Activating Molecular Chaperones (Retracted Article)

被引:173
作者
Donmez, Gizem [1 ,2 ]
Arun, Anirudh [1 ,2 ]
Chung, Chee-Yeun [4 ]
McLean, Pamela J. [3 ]
Lindquist, Susan [4 ]
Guarente, Leonard [1 ,2 ]
机构
[1] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA 02139 USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA
[4] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
关键词
PARKINSONS-DISEASE; NACP/ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASE; CALORIE RESTRICTION; ALZHEIMERS-DISEASE; TOXICITY; STRESS; MODELS; HSP70; MICE;
D O I
10.1523/JNEUROSCI.3442-11.2012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synuclein is a key molecule in the pathogenesis of synucleinopathy including dementia with Lewy bodies, Parkinson's disease, and multiple system atrophy. Sirtuins are NAD(+)-dependent protein deacetylases that are highly conserved and counter aging in lower organisms. We show that the life span of a mouse model with A53T alpha-synuclein mutation is increased by overexpressing SIRT1 and decreased by knocking out SIRT1 in brain. Furthermore, alpha-synuclein aggregates are reduced in the brains of mice with SIRT1 overexpression and increased by SIRT1 deletion. We show that SIRT1 deacetylates HSF1 (heat shock factor 1) and increases HSP70 RNA and protein levels, but only in the brains of mice with A53T and SIRT1 expression. Thus, SIRT1 responds to alpha-synuclein aggregation-induced stress by activating molecular chaperones to protect against disease.
引用
收藏
页码:124 / 132
页数:9
相关论文
共 32 条
[1]   The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by α-synuclein or amyloid-β (1-42) peptide [J].
Albani, Diego ;
Polito, Letizia ;
Batelli, Sara ;
De Mauro, Stefania ;
Fracasso, Claudia ;
Martelli, Giuliana ;
Colombo, Laura ;
Manzoni, Claudia ;
Salmona, Mario ;
Caccia, Silvio ;
Negro, Alessandro ;
Forloni, Gianluigi .
JOURNAL OF NEUROCHEMISTRY, 2009, 110 (05) :1445-1456
[2]   Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration [J].
Araki, T ;
Sasaki, Y ;
Milbrandt, J .
SCIENCE, 2004, 305 (5686) :1010-1013
[3]   NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Arakawa, K ;
Hirai, S ;
Nakamura, M ;
Tonozuka-Uehara, H ;
Kawai, M .
ACTA NEUROPATHOLOGICA, 1998, 96 (05) :439-444
[4]   Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Hirai, S ;
Izumiyama, Y ;
Tonozuka-Uehara, H ;
Kawai, M .
BRAIN RESEARCH, 1998, 808 (01) :93-100
[5]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[6]   SIRT1 transgenic mice show phenotypes resembling calorie restriction [J].
Bordone, Laura ;
Cohen, Dena ;
Robinson, Ashley ;
Motta, Maria Carla ;
van Veen, Ed ;
Czopik, Agnieszka ;
Steele, Andrew D. ;
Crowe, Hayley ;
Marmor, Stephen ;
Luo, Jianyuan ;
Gu, Wei ;
Guarente, Leonard .
AGING CELL, 2007, 6 (06) :759-767
[7]   The role of molecular chaperones in human misfolding diseases [J].
Broadley, Sarah A. ;
Hartl, F. Ulrich .
FEBS LETTERS, 2009, 583 (16) :2647-2653
[8]   Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice [J].
Cheng, HL ;
Mostoslavsky, R ;
Saito, S ;
Manis, JP ;
Gu, YS ;
Patel, P ;
Bronson, R ;
Appella, E ;
Alt, FW ;
Chua, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :10794-10799
[9]   Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction [J].
Cohen, Dena E. ;
Supinski, Andrea M. ;
Bonkowski, Michael S. ;
Donmez, Gizem ;
Guarente, Leonard P. .
GENES & DEVELOPMENT, 2009, 23 (24) :2812-2817
[10]   Parkinson's disease: Mechanisms and models [J].
Dauer, W ;
Przedborski, S .
NEURON, 2003, 39 (06) :889-909